DCI Research

Gloria Bass, MA, has been a part of the Duke Health family for 41 years, including 26 years at DCI.

Co-leader of the DCI Melanoma Disease Group Georgia Beasley, MD, MHSc, is among 40 recipients of a Young Physician-Scientist Award from The American Society for Clinical Investigation.

As Duke celebrates its 50th anniversary of transforming cancer discovery and care, researchers and providers look toward the next half century. 

DCI health services researcher Devon Check, PhD, is co-PI on an NIA grant to study risks of co-prescribed opioids & BZDs in older cancer patients.

The Duke Cancer Institute is excited to announce the establishment of the Duke Sarcoma Center, a center of excellence for sarcoma treatment and research.

The V Foundation Victory Ride to Cure Cancer returns 4.21 to 5.21 (virtual) and May 21 in person with cycling on greenways & roads and on-site spin classes.

The Duke Center for Brain & Spine Metastasis presents its second annual national colloquium, May 13 & 14.

An endowed professorship for David Harpole, Jr., MD, will support his ongoing translational and clinical research in lung cancer.

A DCI research team led by Zachary Hartman, PhD, has described a newly identified process for how the drug pertuzumab works in tandem with trastuzumab.

Kris Wood's research team has discovered a potential strategy to make targeted therapies that are currently under investigation work better & last longer.

“Each time there are new diagnostic tools and there are new treatments. I've been following the wave for 22 years now." — prostate cancer survivor Michael Johnstone.

About one in seven breast cancers detected by mammography screening are over-diagnosed, according to a Duke Cancer Institute study

Duke University School of Medicine ranks 3rd among academic medical centers in the amount of federal medical research funding it receives.

Duke is committed to addressing barriers to early detection of cervical cancer, & mechanisms for screening worldwide through education, tech & cultural awareness.
 

Elizabeth R. Hughes, PhD, an MGM postdoc, studies how gut microbes improve response to immune checkpoint inhibitors. She's been named a 2022 Robert Black Fellow by the Damon Runyon Cancer Research Foundation.

Zhao Zhang, PhD — ZZ to just about everyone — is a bit of a scientific outlier.

Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.

The Eighth Annual DCI Scientific Retreat was one for the books.

New NCCN cervical cancer patient guidelines were released in December. Junzo Chino, MD, is on the guidelines panel.

Tomi Akinyemiju, PhD, meticulously studies what drives cancer outcomes in populations in the United States and across the globe. 

Duke Cancer Institute researchers Jiaoti Huang, MD, PhD, Brant Inman, MD, and Qing Cheng, PhD, have identified a molecular signature that can spot aggressive cells.

The $50,000 grant will support research by Chuan-Yuan Li, DSc, into the ability of cholesterol-lowering drugs to boost cancer-drug immunotherapies.

There's nothing like cancer, many survivors say, to remind you that nothing is guaranteed. Good or bad. Renee Garber got an unexpected "bonus year."

The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.

Furong Huang PhD, a postdoctoral fellow in the Wang Lab, received a Department of Defense Prostate Cancer Research Program Early Investigator Award.

Looking for a great read on how to develop, integrate, & implement a comprehensive cancer center? A new open-access book co-authored by Nelson Chao, MD, MBA, is now available.

The annual Web of Science™ citation index includes 38 researchers at Duke.

A survey of parents & caregivers of children with cancer found that nearly a third of them expressed hesitancy to vaccinate their youngsters against COVID-19.

Holly Dressman has been named director of Duke’s Sequencing and Genomic Technologies (SGT) Core Facility. Nicolas Devos, PhD, has stepped down from his role as SGT director.

Join us for an educational symposium on prostate and urologic cancers on Nov. 5 & the return of the Tackle Cancer Tailgate on Nov. 6.

Sydnee Crankshaw, MPA, has been named Senior Research Program Leader for DCI’s "Cancer Prevention and Control" and "Cancer Risk, Detection, and Interception" programs.

After a 30-year career in clinical cancer research nursing at Duke, Susan Boulton, RN, BSN, has announced her retirement, effective October 29. 

New NCCN Guidelines released for basal cell skin cancer, the most common type of cancer. DCI's Rachel Blitzblau, MD, PhD, panel vice-chair, weighs in.

The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.

A DCI-led research team has identified how melanoma tumors use estrogen signaling to trick the immune system into leaving them alone.

Study led by Tomi Akinyemiju, PhD, finds racial disparities in lung cancer outcomes erased by equal access to top treatments.

The gloves are on in the fight against breast cancer. See you at sunrise, Oct. 23 !

The $3 million National Science Foundation grant is for training Master’s and PhD students at Duke in engineering, computer science, data science, & surgical technologies.

Duke Cancer Institute member Joseph Heitman, MD, PhD, has been elected to the German National Academy of Sciences Leopoldina.

Dukes receives two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Function (IGVF) Consortium.

The event, which also featured talks from Henrietta Lacks’ great-granddaughter and a bioethics leader at Tuskegee University, drew more than 750 viewers worldwide.

Hai Yan, MD, PhD, was awarded the International Prize for Translational Neuroscience for identifying genetic mutations linked to gliomas.

New study on cholesterol and breast cancer finds link between high cholesterol and worsening cancer spread.

Shelley Hwang, MD, vice chair of Research in the Department of Surgery, is renowned for her work in pre-invasive breast cancer.

The $1.25 million grant from the Cancer Research Institute will support brain tumor immunotherapy research

DCI molecular biologist Jason Somarelli, PhD, utilizes comparative and evolutionary biology in his cancer research.

Cheyenne Corbett, PhD, with DCI's Supportive Care & Survivorship Center and Center for Onco-Primary Care, weighs in on the findings.

J. Michael Cook, PhD, assistant professor in the Department of Immunology and co-leader of the Flow Cytometry Shared Resource has passed away.